+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiac Marker Analyzer Market & Product Analysis, By Analyzers (Alere Meterpro Analyzer, RAMP 200, RAMP Reader, etc) & Companies

  • PDF Icon


  • 108 Pages
  • July 2018
  • Region: Global
  • Renub Research
  • ID: 4590299

Global Cardiac Marker Analyzer Market is projected to cross US$ 4 Billion by the year 2024. Cardiac Marker Analyzer (Cardiac Reader Systems) offers a high point of care testing results for the diagnosis of cardiac-related diseases like myocardial infarction and others. Cardiac Marker Analyzer performs all cardiac monitoring tests such as Troponin, Myoglobin, CK-MB and D-Dimer tests, through immunochromatographic assays. Cardiac marker analyzer efficiency and accuracy can be increased with the help of dedicated software and system which offers extensive support to diagnostic procedures and built-in LCD displays for the visualization of practices.

Cardiac Markers Analyzers usually measure the levels of enzymes and proteins released from heart muscle when it is damaged. Physicians use cardiac markers in two ways - to diagnose a cardiac event in a hospital emergency room or within the hospital or to evaluate a risk of a cardiovascular event occurring.

Some of the major Cardiac Marker Analyzers which are frequently used in the diagnosis of patient’s cardiac conditions include i-STAT System, RAMP Reader, RAMP 200, QL Care Analyzer, Access 2 Immunoassay System, Meritas POC Analyzer, Alere Meterpro Analyzer, PATHFAST Analyzer, Stratus CS Analyzer, Cobas H 232 POC System, ichroma DUO Analyzer and DXpress Reader Analyzer.

Cardiac Marker Analyzers plays an important role in the prevention of the misdiagnoses of heart conditions. Increasing prevalence of heart-related diseases across the globe and growing awareness among people about the cardiovascular diseases is expected to drive the demand for Cardiac Marker Analyzers for the diagnosis of cardiac diseases.

This report titled “Cardiac Marker Analyzer Market & Product Analysis, By Analyzers (Alere Meterpro Analyzer, RAMP 200, RAMP Reader, The i-STAT System, cobas h 232 POC System, Stratus CS Analyzer, Access 2 Immunoassay System, ichroma DUO Analyzer, DXpress Reader Analyzer, PATHFAST Analyzer, Meritas POC Analyzer, QL Care Analyzer), Companies (Abbott Laboratories, Getein Biotechnology, Siemens Healthcare, Beckman-Coulter, Alere, Response Biomedical, Roche Diagnostics, Boditech, LifeSign, LSI Medience Corporation, Trinity Biotech, CardioGenics)” provides a complete analysis of Cardiac Marker Analyzer Products.

All the 12 Cardiac Marker Analyzers in the report have been studied from 6 viewpoints.

1. Cardiac Marker Analyzer Market
2. Analyzer Specifications and Benefits
3. Net Product Sales
4. Merger, Acquisition & Licensing Agreement
5. Marketing Strategies
6. Methods of Distribution

12 Cardiac Marker Analyzer studied in the report are as follows:

1. Alere Meterpro Analyzer
2. RAMP 200
3. RAMP Reader
4. The i-STAT System
5. cobas h 232 POC System
6. Stratus CS Analyzer
7. Access 2 Immunoassay System
8. ichroma DUO Analyzer
9. DXpress Reader Analyzer
10. PATHFAST Analyzer
11. Meritas POC Analyzer
12. QL Care Analyzer

Company Analysis

  • Abbott Laboratories
  • Getein Biotechnology
  • Siemens Healthcare
  • Beckman-Coulter
  • Alere
  • Response Biomedical
  • Roche Diagnostics
  • Boditech
  • LifeSign
  • LSI Medience Corporation
  • Trinity Biotech
  • CardioGenics

Table of Contents

1. Executive Summary2. Cardiac Marker Analyzer Market (2011 - 2024)3. Cardiac Marker Companies - Comparative Tests Analysis4. Cardiac Marker Analyzer - Competitive Product Analysis
5. Alere
5.1 Alere Triage
5.1.1 Triage MeterPro Analyzer
5.2 Alere Cardiology Net Sales & Forecast (2011 - 2022)
6. Response Biomedical
6.1 Cardiovascular Testing
6.1.1 Acute Myocardial Infarction (Heart Attack) Testing
6.1.2 Congestive Heart Failure (“CHF”) Testing
6.1.3 Thrombotic Disease Testing
6.2 RAMP Platform
6.2.1 RAMP 200
6.2.2 RAMP Reader
6.3 Response Biomedical Cardiovascular Net Sales
7. Abbott Point of Care
7.1 The i-STAT System
7.2 Abbott Laboratories Point of Care Diagnostics Sales (2011 - 2024)
8. Roche
8.1 Cobas h 232 POC System
9. Siemens Healthineers
9.1 Stratus CS Analyzer
9.2 Siemens Healthineers establishes global Digital Ecosystem to drive Digitalization of Healthcare
10. Beckman Coulter
10.1 Access 2 Immunoassay System
11. Boditech
11.1 i-chroma DUO Analyzer
12. Lifesign
12.1 DXpress Reader Analyzer
13. LSI Medience Corporation
13.1 PATHFAST Analyzer
14. Trinity Biotech
14.1 Meritas POC Analyzer
14.2 Trinity Biotech Point of Care Diagnostics Sales (2011 - 2024)
15. CardioGenics Holdings Inc.
15.1 QL Care Analyzer
16. Mergers, Acquisitions and Licensing Agreements
16.1 Alere Inc
16.2 Response Biomedical
16.3 Abbott Laboratories
16.4 Siemens Healthineers
16.5 LSI Medience Corporation
16.6 Trinity Biotech
16.7 CardioGenics
17. Emerging Markers
18. Response Biomedical - Business & Marketing Strategy
18.1 Reducing Research & Development (R&D) and Sales & Marketing Expenses under the Cost Reduction Strategy
18.2 New Distributors in China
18.3 Strategic Alliances with Alere Medical in Japan
18.4 Response Biomedical Receives Health Canada Approval and CE Mark
19. Roche - Business & Marketing Strategy
19.1 Implementing the Fully Connected Core Laboratory
19.2 Expansion of Rich Test Menu
19.3 Broadening the Diagnostics Portfolio
19.4 Patient Safety Comes First
20. Siemens Healthineers - Business and Marketing Strategy
20.1 Siemens Healthineers Announces New Strategic Relationship
20.2 Cloud-Based Network Teamplay from Siemens Healthineers
20.3 Strategic Partnership between Siemens and Imricor
20.4 Siemens Healthineers Offers True High-Sensitivity Troponin I IVD Assay
20.5 Siemens Healthineers & Digitalization
20.6 Partnership between Siemens Healthineers and Ebit
21. Boditech Med Inc - Business and Marketing Strategy
21.1 Boditech Med Acquires Immunostics
21.2 Strong Focus on Manpower and Investments in Research & Development Area
21.3 Advanced Technology in the Diagnostics Market
21.4 Marketing Channel
List of Figures
Figure 2-1: Global - Cardiac Marker Market (Billion US$), 2011 - 2017
Figure 2-2: Global - Forecast For Cardiac Marker Market (Billion US$), 2018 - 2024
Figure 5-1: Worldwide - Alere Cardiology Net Sales (Million US$), 2011 - 2016
Figure 6-1: Worldwide - Response Biomedical Cardiovascular Product Sales (Million US$), 2011 - 2016
Figure 7-1: Worldwide - Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2011 - 2017
Figure 7-2: Worldwide - Forecast for Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2018 - 2024
Figure 8-1: WIFI Set-up
Figure 8-4: Connectivity of cobas h 232 in pre-hospital care and within hospital Set-up
Figure 14-1: Worldwide - Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2011 - 2017
Figure 14-2: Worldwide - Forecast for Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2018 - 2024
Figure 21-1: Boditech - R&D Manpower, Jan 2016
Figure 21-2: Boditech - R&D Investments (Million US$), Jan 2016
List of Tables
Table 2-1: Cardiac Marker Companies - Comparative Tests Analysis
Table 2-2: Cardiac Marker Companies - Comparative Tests Analysis
Table 2-3: Cardiac Marker Companies - Comparative Tests Analysis
Table 3-1: Cardiac Marker Analyzer - Competitive Product Analysis
Table 3-2: Cardiac Marker Analyzer - Competitive Product Analysis
Table 6-1: i-STAT 1 Analyzer Specification
Table 12-1: PATHFAST - Technical Specifications
Table 15-1: Mergers, Acquisitions and Licensing Agreements, 2003 - 2017
Table 18-1: Roche - Centralised and Point of Care Solutions Product Launches, 2017
Table 18-2: Roche - Molecular Diagnostics Product Launches, 2017
Table 18-3: Roche - Tissue Diagnostics Product Launches, 2017
Table 18-4: Roche - Sequencing Product Launches, 2017

Companies Mentioned

  • Abbott Laboratories
  • Alere
  • Beckman-Coulter
  • Boditech
  • CardioGenics
  • Getein Biotechnology
  • LifeSign
  • LSI Medience Corporation
  • Response Biomedical
  • Roche Diagnostics
  • Siemens Healthcare
  • Trinity Biotech


In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts